Microtubule-perturbing drugs have become front-line chemotherapeutics, inducing cell-cycle crisis as a major mechanism of action. However, these agents show pleiotropic effects on cells and can induce apoptosis through other means. Paclitaxel, a microtubule-stabilizing agent, induces a caspase-dependent apoptosis, although the precise mechanism(s) remain unclear. Here, we used genetic approaches to evaluate the role of caspase 8 in paclitaxel-mediated apoptosis. We observed that caspase 8-expressing cells are more sensitive to paclitaxel than caspase 8-deficient cells. Mechanistically, caspase 8 was found associated with microtubules, and this interaction increased after paclitaxel treatment. The prodomains death effector domains (DEDs) of caspase 8 were sufficient for interaction with microtubules, but the caspase 8 holoprotein was required for apoptosis. DEDonly forms of caspase 8 were found in both primary and tumor cell lines, associating with perinuclear microtubules and the centrosome. Microtubule association, and paclitaxel sensitivity, depends on a critical lysine (K156) within a microtubule-binding motif (KLD) in DED-b of caspase 8. The results show an unexpected pathway of apoptosis mediated by caspase 8.
Introduction
Microtubule-targeted agents are used as antimitotic drugs. These agents comprise several different classes of molecules, and may induce cell death through more than one mechanism (Gascoigne and Taylor, 2008) . Caspase activation (Bayless and Davis, 2004; Kasibhatla et al., 2007; Kim et al., 2008; Petit et al., 2008) and 'noncaspase protease' (Mitsui et al., 2001) activities have been reported. Paclitaxel is a microtubule-stabilizing drug linked to the activation of numerous caspases, including caspases 3, 8 and 10 (Wieder et al., 2001; von Haefen et al., 2003; Park et al., 2004) . In these cases, apoptosis is blocked by broad-spectrum caspase inhibitors and occurs in a 6-to 24-h time period. In contrast, the induction of apoptosis after cell-cycle crisis is observed between 24 and 72 h.
It remains unclear whether initiator caspases (8 and 10) actually activate before caspase 3 to 'initiate' cell death or become activated as bystanders (Wieder et al., 2001; von Haefen et al., 2003) . In this study, we used a genetic approach to examine the interaction between paclitaxel and caspase 8. We examined the efficacy of paclitaxel at inducing apoptosis among cells in which caspase 8 expression was altered, either through shRNA approaches or by reconstitution of genetically deficient cell lines. The approach permitted an evaluation of the impact of caspase 8 in live cells while avoiding the pleiotropic (off-target) effects associated with caspase inhibitors (Rozman-Pungercar et al., 2003) .
Caspase 8 is composed of a catalytic domain and a prodomain region, the latter containing two 'death effector domains' (DEDs). During maturation of the caspase 8 zymogen (also called procaspase 8), the DEDs are cleaved from the catalytic domain, the catalytic domain dimerizes and the mature caspase 8 catalytic unit is formed. The sequence of the catalytic domain is highly conserved among the different caspases, whereas DEDs are present only in caspases 8 and 10, and belong to the 'death domain' family composed of proteins that influence cell death and proliferation (Weber and Vincenz, 2001; Tibbetts et al., 2003) . DEDs can act as protein 'adaptor' domains, interacting with other DED modules and likely with other proteins as well (Tang and Tai, 2007) . In the case of caspase 8, DEDs have been implicated in cell proliferation (Kennedy et al., 1999; Pellegrini et al., 2005) , the induction of apoptosis and prevention of apoptosis (Shikama et al., 2002) . DED functions appear dependent on their expression pattern and subcellular localization (Barnhart et al., 2003; Tibbetts et al., 2003; Yao et al., 2007) .
In this respect, caspase 8 is found at a number of different cellular locations. Cell behavior influences caspase 8 targeting. For example, caspase 8 can be found within the lamella of migrating cells (Barbero et al., 2008) . Here, we assessed whether perturbation of the cytoskeleton by paclitaxel influenced caspase 8 localization or activity. Surprisingly, we found that paclitaxel induced caspase 8-dependent cell death, and that mechanistically, the association of the DEDs of caspase 8 with microtubules promoted cell death.
Results
Cells that express caspase 8 show increased sensitivity to paclitaxel To characterize the role of caspase 8 in cellular susceptibility to paclitaxel, we evaluated the sensitivity of the caspase 8-deficient neuroblastoma cell line, NB7 (Stupack et al., 2006) , and cells expressing caspase 8 (Figure 1a and Supplementary Figures 1 and 2) . Within 16 h, paclitaxel induced greater apoptosis among the caspase 8-expressing cells (Figure 1a ). We tested apoptosis in Jurkat cells that were deficient for caspase 8 or were reconstituted for caspase 8 expression treated with a microtubule-stabilizing agent, such as paclitaxel or a microtubule de-stabilizing agent, such as nocodazole (Beisner et al., 2003) for 6 and 24 h (before the induction of mitotic arrest), and determined that the caspase 8-deficient Jurkat cells were less susceptible to paclitaxel-induced killing (Figure 1b and Supplementary Figure 1A ). By contrast, nocodazole induced similar (low) levels of apoptosis among caspase 8-positive and caspase 8-negative Jurkat cells after brief exposure that did not induce mitotic arrest (Figure 1b) . Similarly, agents that activate alternative apoptosis pathways, such as staurosporine, induce similar levels of apoptosis in cells expressing or lacking caspase 8 (Supplementary Figure 1B , right panel) (Teitz et al., 2002; Stupack et al., 2006) . To extend our examination of this acute response, we next treated the cells with paclitaxel or nocodazole for 6 h ('pulse') to induce a proapoptotic stimulus and then washed the cells to remove excess drug. This did not influence the survival of caspase 8-negative, as assessed 20 h later ( Figure 1c ). By contrast, a 6-h exposure to paclitaxel was sufficient to initiate an apoptotic response among caspase 8-expressing cells similar to that observed if paclitaxel was not removed (Figure 1c and Supplementary Figure 1B) . Thus, stabilization of microtubules by paclitaxel within 6 h can trigger an early, caspase 8-dependent proapoptotic event ( Figure 1c ). To assess the generality of the results, we next suppressed the expression of endogenous caspase 8 in NB5 cells. In agreement with the prior studies, knockdown of endogenous caspase 8 within Paclitaxel promotes casp 8 binding to microtubules A Mielgo et al NB5 neuroblastoma cells was found to decrease their susceptibility to paclitaxel (Figure 1d ). Similarly, reconstitution of physiological levels of the caspase 8 expression in the NB7 cells (NB7C8) (Stupack et al., 2006) promoted paclitaxel-induced apoptosis ( Figure 1d ). Together, these results implicate caspase 8 as having a causal function in promoting an 'early', paclitaxelmediated apoptotic response.
Caspase 8 associates with microtubules and centrosomes Caspase 8 can be recruited to a number of distinct subcellular sites, including the peripheral lamella of migrating cells (Barbero et al., 2008) and endosomes of apoptotic (Schneider-Brachert et al., 2004) and nonapoptotic cells (Torres et al., 2008) . To assess the influence of paclitaxel on the subcellular distribution of caspase 8, we used confocal image analysis. Endogenous caspase 8 localizes with different cellular regions; however, of particular interest to these studies was an apparent filamentous distribution that colocalized with tubulin in several cell lines (Figure 2a and Supplementary Figure 3 ). This colocalization was increased by twofold by co-incubation with the microtubulestabilizing agent paclitaxel (Figure 2a , middle panels, Figure 2b , Po0.01 and Supplementary Figure 3 ). However, in the presence of the microtubule de-stabilizing agent, nocodazole, this colocalization appeared to decrease (Figure 2a , low panels, Figure 2b and Supplementary Figure 3 ). Microtubule association was exclusive to caspase 8 as we did not observe colocalization of other caspases with microtubules ( Figure 2b and data not shown). As paclitaxel acts to stabilize microtubules, this observation raised the notion that the association of caspase 8 with microtubules might contribute to apoptosis. To evaluate the mechanism by which caspase 8 associates with microtubules, we next used green fluorescent protein (GFP)-tagged constructs of the caspase 8 holoprotein, as well as the N-and C-terminal domains of caspase 8, and assessed their subcellular distribution ( Figure 2c ). As shown, the N-terminal domains (DEDs) of caspase 8 showed a filamentous distribution; these filaments colocalized with an antitubulin antibody ( Figure 2d , and Supplementary Figure  4 ). We were unable to show significant colocalization with other subcellular compartments, including actin filaments or the Golgi. His-tagged DEDs showed a similar localization to the GFP-tagged constructs, suggesting that the DEDs, rather than GFP, mediated the interaction with microtubules (Figure 2c , left panel and Supplementary Figure 4B ). In support of these findings, DEDs-GFP, but not GFP alone, immunoprecipitated with tubulin (Supplementary Figure 4C ). It can be noted that the localization of the DEDs in these cells was usually perinuclear, a site where microtubule turnover is less dynamic than in the cell periphery. Together with the observation that paclitaxel increased caspase 8 association with microtubules, the results suggest that DEDs might associate preferentially with 'stable' microtubules.
We were aware that DEDs have previously been described to form filaments in cells (Siegel et al., 1998) and that DED filaments were suggested to form spontaneously through a direct DED-DED association. In agreement with this notion, DEDs can aggregate in cell-free systems (and indeed, we do find that DEDs will aggregate after expression in bacterial systems) (D.G. Stupack, unpublished observations). However, free DEDs have not been described to form filaments. We therefore speculated that interactions promoted by a microtubule scaffold might account for the formation of the 'filaments.' To directly assess whether microtubules influenced DED filaments, we treated caspase 8-deficient cells expressing the DED-GFP with either paclitaxel (to stabilize microfilaments) or nocodazole (to disrupt microfilaments). Paclitaxel increased the incidence and length of DED microfilaments, as assessed in either live or fixed cells ( Figure 3a ). By contrast, treatment with nocodazole disrupted DED filaments (Figure 3a ), frequently resulting in a punctate distribution of DED (a nonfilamentous aggregate). Together, the results were consistent with the notion that (stable) microtubules are important for DED colocalization and 'filament' formation.
The DEDs were frequently observed in a characteristic stellate appearance reminiscent of centrosomes ( Figure 3b ), and we subsequently confirmed that the DEDs were centrosome associated through cell fractionation and centrosome purification (Figure 3c ). Localization of caspase 8 DEDs at the centrosome was not an artifact of expressing DED-GFP, as an antibody to the caspase 8 DEDs also detected endogenous caspase 8 at the centrosomes (Figure 3c , left panels). Endogenous DEDs also colocalized with centrosomes ( Figure 4b and Supplementary Figure 5 ) and were detected within the purified centrosome fraction (Figure 4b , right panel). However, the DEDs are not detected at the centrosomes of cells that do not express caspase 8 (Supplementary Figure 5 ).
The DEDs of caspase 8 are present in nonapoptotic cells
It remained unclear whether the caspase 8 holoprotein interacted with microtubules, or whether the interaction was specific to the maturation-processed DED fragments. The DEDs appeared sufficient, and significantly more efficient, at integrating into filaments ( Figure 2c ). An immunofluorescence approach using antibodies specific for either the catalytic domain or the DEDs showed that DEDs frequently colocalized with the catalytic domain. However, interestingly, we also observed areas where principally DED staining was observed ( Figure 4a ). To test this more directly, we next evaluated the localization of DEDs or the caspase 8 catalytic domain with the centrosome (Figure 4b , middle panel). Confocal analysis of the centrosomes showed staining with a DED-specific antibody in almost all cells, but only rarely with an antibody specific to the catalytic domain. Together, the data suggest that mature DEDs are either more efficient at microtubule association than the caspase 8 holoprotein or, alternatively, that caspase 8 maturation may follow microtubule association.
These results further suggest that the DEDs might also be produced from endogenously expressed caspase 8. An immunoblot analysis of nonapoptotic COS-7 cells showed the presence of an N-terminal DED-containing fragment (Figure 4c ). We considered that the DEDs might accumulate as part of a background level of apoptosis within these cell populations; therefore, we looked for a similar accumulation of the C-terminal domain. However, we were consistently unable to detect signs of caspase 8 maturation other than the DEDs (Figure 4c and unpublished observations). Moreover, the expression of the DED fragment was not unique to COS-7 cells, but was found in monocytes, endothelial and epithelial cells, as well as in caspase 8-positive neuroblastoma (Figure 4d ). By contrast, DEDs were not detected in caspase 8-deficient cells (Figure 4e ). Colocalization studies were carried out staining cells for a-tubulin, actin, vimentin, ER, the Golgi, the nuclear envelope, the mitochondria (red channel) and DED-GFP (green channel). Quantification of colocalization between DED-GFP and all the cellular components described was determined using NIH ImageJ Software. Data were analysed with ANOVA followed by post hoc tests (significant differences, *Pp0.05).
Although there was no significant apoptosis in these populations, we speculated that the DEDs could accumulate as a result of low levels of caspase 8 maturation occurring independent of apoptosis (Su et al., 2005; Gdynia et al., 2007) . As caspase 8 clearance is mediated through ubiquitinylation of the catalytic domain (McDonald and El-Deiry, 2004) , the selective retention of mature DEDs appeared reasonable. To explore this possibility, we examined neuroblastoma cells reconstituted with either a catalytically inactive caspase 8 mutant (C360A) or wild-type (wt) caspase 8. Although the basal rate of apoptosis in these populations was similar (B3 to 5%, assessed by fluorescence-activated cell sorting (FACS)), we detected the mature DEDs of caspase 8 selectively in lysates derived from cells reconstituted with active enzyme, and not in those derived from cells expressing the catalytically dead mutant (Figure 4e ). Catalytic activity therefore permits an endogenous degree of DED production. However, we cannot discount the possibility that DED-only proteins could accumulate directly through the expression of caspase 8 isoforms that lack ) were treated with paclitaxel to stabilize microtubules (middle panels), or nocodazole to disrupt microtubules (lower panels) relative to DMSO controls (top panels). Localization of -DED-GFP in living (left column) or fixed (right column) cells was assessed through confocal microscopy. Fixed cells were stained with Topro to label nuclei (blue channel) (scale bar ¼ 10 mm). (b) Extended confocal microscopy studies were carried out for staining cells for the nucleus (Topro, blue channel) and DED-GFP (green channel). DED-GFP formed an aster in the perinuclear region as shown in the paired bright field and fluorescent images. (c) Centrosome fractions were purified from these cells by differential centrifugation (purified centrosomes), and probed for the presence of g-tubulin, a centrosome marker, as well as for the caspase 8-DEDs. Purity of the preparations was assessed by immunoblot analysis of markers from potential contaminating fractions, including the Golgi (GM130), a endoplasmic reticulum marker (PDI), or a nuclear envelope marker (Lamin B). No contamination was detected in the purified centrosome (p.Cen) preparations relative to total material (input).
the catalytic domain, such as caspase 8 D, E and G .
DEDs promote caspase 8-dependent apoptosis
We assessed whether association of the DEDs was sufficient to induce apoptosis. We found that simple DED expression in COS-7 or 293 cells was sufficient to induce apoptosis ( Figure 5) ; however, no apoptosis was observed in the caspase 8-deficient NB7 cells. When DEDs were expressed in caspase 8 reconstituted NB7C8 cells, we observed subsequent activation of the caspase 8 holoenzyme and apoptosis ( Figure 5 ). Thus, paclitaxel and DEDs required a pool of catalytically active caspase 8 to promote apoptosis. These results raised the notion that microtubules might serve as a scaffold to recruit and activate caspase 8.
DED-b is critical for microtubule association
Using a truncation mutation approach, we found that DED-b expression was sufficient to promote microtubule binding (Figure 6a, table) . DED-a did not localize to microtubules. We next extended this result using a point mutagenesis strategy, specifically targeting charged residues within the inter-helix loops of DED-b ( Figure 6a ). As shown, the K156R mutation in the helix 4-helix 5 loop of DED-b disrupted recruitment to microtubules (Figures 6a and b) . In contrast, mutation of residues in other loops had no effect on microtubule association of the DEDs. Interestingly, the K156R mutation decreases within a microtubule-binding motif (KLD) in the loop/turn between helices 4 and 5 in DED-b. This motif is shared with the 'IR1/2' region (inter-repeat 1/2 region) of the microtubule-binding proteins Tau (Goode and Feinstein, 1994) and MAP2C/D as well as of the microtubule 'cleft-binding finger' of M-type kinesins (Blaineau et al., 2007) . Mutation of the lysine in this motif also inhibits microtubule association mediated by the IR1/2 region of Tau (Goode and Feinstein, 1994) and tubulin cleft binding by KIF2C (Ogawa et al., 2004) . Confocal microscopy analysis and co-staining for g-tubulin showed that the K156R mutation blocked association with centrosomes ( Figure 6c ). As microtubule association mapped to a distal loop in DED-b, the 'DED-binding' RxDL motif would be located at the opposite end of the DEDs in DED-a (Garvey et al., 2002b) . This prompted us to consider whether the two DED domains might operate cooperatively to induce apoptosis.
Microtubule accumulation of DEDs promotes the caspase 8 component of paclitaxel-induced apoptosis
As paclitaxel promotes localization of caspase 8 with microtubules and induces a caspase 8-dependent apoptosis, we hypothesized that DED association with microtubules might be important to activate a caspase- dependent component of paclitaxel-induced apoptosis. We tested whether differences existed in apoptosis induced by paclitaxel in cells expressing procaspase 8 or those expressing a procaspase 8 mutant deficient in microtubule binding (C8-K156R). Expression of a microtubule-binding mutant of caspase 8 rendered cells resistant to paclitaxel treatment, whereas cells expressing wt caspase 8 remained sensitive to paclitaxelinduced, caspase-dependent killing (Figure 7a) . These results suggested that microtubule association of caspase 8 might be important for paclitaxel-mediated triggering of caspase 8. We next tested whether DED decoration of microtubules was sufficient to induce apoptosis independent of paclitaxel. In cells lacking caspase 8, neither wt DED nor K156R mutants induced apoptosis. However, among caspase 8-expressing cells, the DEDs strongly induced apoptosis and caspase 8 activation, whereas expression of the KLD mutant DEDs did not (Figure 7b ). Together, the results suggested that microtubule association of DEDs was important for subsequent caspase 8 activation.
Testing this through immunofluorescence analysis, we observed a dramatic change in procaspase 8 distribution after expression of DEDs (Figure 7c ). Wild-type caspase 8 was found to be recruited to microtubule-associated DEDs (Figure 7c, left middle panels) . Moreover, the recruitment of mutant full-length caspase 8 bearing the K156R mutation to microtubules was rescued by coexpression of wt DEDs (Figure 7c, right middle panels) . The results show that although the K156R mutation prevents direct interaction with microtubules, it does not prevent homotypic interactions (direct DED-DED interactions) that are known to occur through the DEDa domain (Figure 7c ). Consistent with these results, both wt caspase 8 and caspase 8 bearing the K156R mutant induced apoptosis in the presence of wt DEDs (Figure 7d ). As expected, neither K156R (data not shown) nor wt caspase 8 (Figure 7c , right panels) was found associated with microtubules in the presence of the mutated K156R DED domains.
On the basis of this, we evaluated whether the expression of DEDs would enhance paclitaxel-induced apoptosis. Paclitaxel-mediated apoptosis was promoted by wt DEDs, but not by the K156R mutant (Figure 7e and Supplementary Figure 6 ). The expression of DEDs displayed no synergy with nocodazole, a microtubuledestabilizing drug (interestingly, there was a trend toward decreased apoptosis). These observations indicate that the microtubule-binding function of the DEDs is important for the caspase 8-mediated cell death after acute paclitaxel exposure. Together, our studies suggest that the paclitaxel efficacy may require only an exposure of a few hours to kill some tumor targets (much briefer than that required for mitotic arrest), and further define a new mechanism in which microtubule-scaffolded DEDs contribute to caspase 8 activation.
Discussion
Paclitaxel induces cell-cycle arrest and/or crisis, promoting cell death. These studies focused on the early, caspase 8-dependent apoptotic response resulting from the recruitment of mature DEDs to microtubules. Finding that caspase 8 expression results in increased apoptosis, we determined that the caspase-dependent response was also microtubule-dependent. The accumulation of DEDs on microtubules potentiates caspase 8 recruitment and promotes caspase activation and cell death. It is conceivable that similar events could occur during the early stages of death-receptor-mediated killing, wherein an initial modest accumulation of DEDs on microtubules could act to amplify receptor-mediated caspase 8 activation. Indeed, in our hands, expression of DEDs or paclitaxel acts synergistically to promote apoptosis through Fas (A Mielgo, DG Stupack, unpublished observations) . Microtubule-stabilizing agents that could promote the microtubule-DED complex would therefore be predicted to amplify ongoing caspase 8 activation, acting as a second surrogate 'death-inducing signaling complex' (DISC). Such a positive feedback loop would provide one explanation for the synergies observed between taxanes and death receptor ligands (Nimmanapalli et al., 2001; Odoux et al., 2002; Singh et al., 2003; Odoux and Figure 7 Recruitment to microtubules promotes caspase 8-mediated apoptosis. (a) Neuroblastoma cells deficient in caspase 8 (NB7) were reconstituted with caspase 8 or the microtubule-binding mutant of caspase 8 (Casp8-K156), treated with paclitaxel (400 ng/ml) and apoptosis was assessed relative to untreated controls. (b) Quantification of apoptosis in neuroblastoma cell-deficient (NB7) orexpressing (NB7C8) caspase 8 after the expression of wt DEDs or those deficient in microtubule binding (K156R-GFP) (10 mg transfected). Caspase 8 processing during apoptosis was assessed by immunoblot analysis of these lysates using an antibody reactive to the catalytic domain of caspase 8 (inset). For all panels, data shown are the mean ± s.d. from triplicate determinations. Data were analysed with Mann-Whitney U-test (significant differences, *Pp0.05). (c) Immunofluorescence images showing the localization of caspase 8 basally in NB7 cells (left panel), or following the expression of DEDs (2 mg transfected). Images of cells that did not appear to be undergoing apoptosis were taken (no nuclear shrinkage or blebbing). Colocalization of either caspase 8 (Casp8) or a mutant caspase 8 lacking the microtubule-binding motif (Casp8 K156R) (red channel) following the expression of GFP-labeled DEDs (green channel) was evaluated (middle panels). Both wt caspase 8 and casp8 K156R constructs showed enhanced recruitment to microtubules by DEDs (merge, yellow channel). The right panels show expression of the K156R DEDs, which is not recruited to microtubules, and does not enhance association of wt caspase 8 with microtubules (scale bar ¼ 10 mm). (d) Quantification of apoptosis induced by DEDs in neuroblastoma cells deficient in caspase 8 (NB7) or reconstituted with wild type or the microtubule-binding mutant of caspase 8 (Casp8-K156), was performed by FACS. (e) Quantification of cell death among 293 cells expressing the DED-GFP or DEDK156R-GFP, and treated with nocodazole or paclitaxel (400 ng/ml for 6 h). Data shown is the mean±s.d. from triplicate determinations, normalized to cell death induced in mock transfected cells, and were analyzed with U Mann-Whitney test (*, significant differences, Pp0.05). Zhu et al., 2004) . Such a model may also explain why microtubule-destabilizing drugs hinder DR-mediated killing (Feng and Kaplowitz, 2000) . The capacity for taxanes to mediate proapopotic action among caspase 8-expressing tumors without requiring cell-cycle arrest could influence efficacy among tumors, particularly those with compromised vascular perfusion.
Albers
The precise molecular mechanism of DED association with the microtubules remains unclear. The interaction appears dependent on a KLD motif, which is also found in class II microtubule-binding proteins, M-type kinesins and some DEDs (Goode and Feinstein, 1994; Al-Bassam et al., 2002 Ogawa et al., 2004; Blaineau et al., 2007) . The motif occurs at the opposite 
Microtubule
Paclitaxel promotes casp 8 binding to microtubules end of the caspase 8 DEDs from the RxDL motif responsible for the DED-DED interaction (Carrington et al., 2006) . The KLD motif is absent from viral DEDs that protect against caspase-8-mediated killing, such as MC159 (Garvey et al., 2002a) . Importantly, K156R procaspase 8 mutants that could not bind microtubules directly could still be rescued in their ability to induce apoptosis by wt DEDs.
The results also suggest that previously described DED 'death effector filaments' are likely microtubule-associated DEDs (Siegel et al., 1998) . Recent studies identifying the regions of DEDs that associate (Garvey et al., 2002b; Carrington et al., 2006) indeed imply that 'excess' DEDs might be expected to compete with procaspase 8 for binding sites (Shikama et al., 2002) , and as a steric consequence, could actually preclude procaspase clustering and activation (Boatright et al., 2003) . By contrast, a microtubule scaffold should promote apoptosis more efficiently, as it could adsorb the DED-b domain directly while allowing the recruitment of additional caspase 8 through the DED-a RxDL motif.
As pointed out recently by Gascoigne and Taylor (2008) , microtubule-targeting drugs have been used broadly in chemotherapeutic applications, despite the fact that we know little about their mechanism of cell killing. In their studies, they showed that prolonged exposure to antimitotic drugs could potentially result in multiple different cell fates. Many cells exhibited heterogeneous responses, possibly due to the differences in drug-target binding, multidrug resistance/transporters, or possibly due to the expression of caspases, such as caspase 8. In this regard, others have shown that caspase 8 activation through TRAIL can accelerate apoptosis induced by mitotic checkpoint drugs (Kim et al., 2008) . In contrast to our results, however, these studies showed a cooperativity between nocodazole and caspase 8-mediated killing, which we do not observe (Figures 1 and 7) , likely through the cleavage of spindle checkpoint proteins. Such differences may be explained, in part, by the fact that our studies focused on the acute cell reaction to paclitaxel and nocodazole. However, we did observe cooperativity between a Fas agonist and paclitaxel ( Supplementary  Figure 7) ; hence, the activation of caspase 8 may be a common 'enhancing' factor for cell death after microtubule perturbation. Indeed, in this case, microtubuleassociated DEDs could act to amplify external apoptosis signals ( Supplementary Figure 8) .
From the clinical perspective, microtubule-based amplification of caspase 8 activation may contribute to the efficacy of caspase 8-dependent drugs, including the DR agonist TRAIL (Odoux and Albers, 2004) , proteasome inhibitors (Calvaruso et al., 2006; Kabore et al., 2006; Miller et al., 2007; Voortman et al., 2007; Chauhan et al., 2008) and, as shown here, taxanes (Nimmanapalli et al., 2001; Wieder et al., 2001; von Haefen et al., 2003) . Such a role for caspase 8 in paclitaxel-mediated effect may well explain the poor impact of paclitaxel in malignant neuroblastoma, which are generally caspase 8-deficient (Teitz et al., 2001; Kretschmar et al., 2004) . However, an improved understanding of the underlying mechanisms by which caspase 8 affects cell death may provide new opportunities to increase efficacy among caspase-8-directed therapies already in clinical use.
Materials and methods

Vectors and constructs
The GFP-caspase 8 constructs have been previously reported (Barbero et al., 2008) . K156R, S113A, E127A and D141A mutations were introduced in DED-GFP using the Quik-Change Mutagenesis Kit (Stratagene, La Jolla, CA, USA) with appropriate mutagenesis primers. DED myc-His fusion protein was shuttled from DED-GFP into pcDNA3.1 myc-His (Invitrogen, Carlsbad, CA, USA).
Cell culture and transfections
Previously described human neuroblastoma cells, deficient or expressing caspase 8 (Stupack et al., 2006) , were cultured in RPMI supplemented with 10% fetal bovine serum, glutamine and non-essential amino acids. Human keratinocytes (HaCaT), human carcinoma cells (A549) and monkey fibroblasts (COS-7) were cultured in Dulbecco's modified Eagle's medium, supplemented as previously described (Stupack et al., 2001) . Human endothelial cells were cultured in M199 with endothelial cell supplement, 10% fetal bovine serum, glutamine and minimal essential amino acids. Neuroblastoma cells deficient in caspase 8 were transfected using the Fugene reagent following the manufacturer's protocol. Stable cell lines were selected with 500 mg/ml of G418 (Gibco, Rockville, MD, USA) and FACS-sorted for GFP-positive cells. Caspase expression was confirmed by immunoblotting with caspase 8 N-terminus-(BD Pharmingen, La Jolla, CA, USA) and C-terminus-specific antibodies (the clones C5 and C15 monoclonal antibodies were a gift from M Peter, University of Chicago, USA). NB7 cells stably transfected with DED-GFP were treated with 600 nM of nocodazole or 200 nM of paclitaxel (Sigma) or DMSO (control) overnight. Living and fixed cells were visualized with a Â 20 or Â 63 objective using a Nikon Eclipse C1 confocal microscope (Los Angeles, CA, USA).
Immunofluorescence studies
Cells attached to coverslips were fixed with 4% paraformaldehyde and permeabilized in phosphate-buffered saline (PBS) containing 0.1% Triton for 3 min and blocked for 60 min at room temperature with 2% bovine serum saline in PBS. The cells were stained with antibodies to the N-terminal DED of caspase 8 (BD Pharmingen and Calbiochem), antibodies specific for a-tubulin (Abcam, Cambridge, MA, USA and Calbiochem, San Diego, CA, USA), g-tubulin (Abcam), pericentrin (Abcam), ER (anti-PDI, Stressgen, San Diego, CA, USA), the Golgi (anti-GM130, Transduction Labs, Lexington, KY, USA), vimentin or actin (Sigma, Carlsbad, CA, USA), lamin B (Santa Cruz Biotechnology, Santa Cruz, CA, USA) or MitoTracker (Invitrogen). All primary antibodies were used at 1:100 dilution, for 2 h at room temperature. After washing several times with PBS, the cells were stained for 2 h at room temperature, with a secondary antibody specific for mouse, rabbit or goat (Invitrogen), as appropriate, diluted 1:300. In some cases, the cells were coincubated with the blue DNA dye TOPRO-3 (1:1000; Invitrogen). Samples were mounted in Vectashield HardSet Mounting Media (Vector Laboratories, Burlingame, CA, USA) and imaged on a Nikon Eclipse C1 confocal microscope with a 1.4 NA Â 60 oil-immersion lens, using minimum pinhole (30 mm). For immunoblot analysis and immunofluor-escence, antibodies specific for the N-terminal DED (BD Pharmingen and Calbiochem) or the C-terminal catalytic domain (clones C5 and C15) , as well as a polyclonal antibody, we raised to the recombinant catalytic domain of caspase 8 here at University of California San Diego (UCSD). For demonstration of centrosome recruitment, pixels thresholding (top 20%) was carried out. Immunofluorescence was also carried out with a mouse monoclonal FADDspecific antibody (BD Pharmingen) and a rabbit polyclonal anti-PEA-15 antibody (Abcam). Images were captured using EZ-C1 3.50 imaging software (Nikon, Los Angeles, CA, USA); they were also analysed for colocalization of signals using ImageJ software (National Institutes of Health).
Cell fractionation, immunoprecipitation and immunoblotting Cells were lysed in either NP40 lysis buffer (150 mM NaCl, 50 mM Tris base (pH 7.4), 1% NP40) or RIPA buffer (50 mM Tris (pH 7.4), 100 mM NaCl, 0.1% SDS) supplemented with the Complete Protease Inhibitor mixture (Roche, Palo Alto, CA, USA), 50 mM NaF and 1 mM Na 3 VO 4 and centrifuged at 13 000 g for 10 min at 4 1C. Protein concentration was determined using bicinchoninic acid (BCA) assay. A total of 500 mg of protein was immunoprecipitated with 2 mg of rabbit anti-GFP antibody (Abcam) at 4 1C overnight, followed by 25 ml of protein A/G (Pierce, Rockford, IL, USA). Beads were washed five times, eluted in boiling Laemmli buffer, resolved on 10% SDS-PAGE (polyacrylamide gel electrophoresis) and immunoblotting was carried out with mouse anti-a tubulin antibody (1:1000). The C5-, C15-and DED1-specific caspase 8 antibodies described under immunofluorescence were used in immunoblotting (5 mg/ml). For immunoblot analysis, 30 mg of protein was boiled in Laemmli buffer and resolved on 10% gel. Centrosomes were isolated from NB7-GFP, NB7 DED-GFP stable cell lines and COS-7 cells according to the protocol of Bornens et al. (1987) . Centrosome fractions were analysed by SDS-PAGE and immunoblotting.
Viability analysis
Cell viability was analysed by flow cytometry following propidium iodide (PI) staining, essentially as described (Hetz et al., 2002) . Briefly, the cells were harvested, resuspended in ice-cold PBS containing 10 mg/ml of PI and analysed by flow cytometry. Apoptosis was determined by gating PI fluorescence versus forward scatter using Cell Quest software.
